| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,713 |
14,244 |
$1.17M |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,930 |
3,987 |
$1.13M |
| 36415 |
Collection of venous blood by venipuncture |
27,421 |
22,187 |
$868K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,454 |
9,020 |
$801K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
362 |
295 |
$568K |
| 8888888 |
Internal/system code - not a standard HCPCS code |
4,875 |
1,309 |
$534K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,866 |
1,185 |
$434K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,108 |
4,468 |
$411K |
| J2704 |
Injection, propofol, 10 mg |
1,985 |
1,656 |
$396K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
787 |
628 |
$348K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,493 |
2,102 |
$314K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,199 |
1,733 |
$309K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,671 |
5,709 |
$295K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,210 |
1,985 |
$294K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,677 |
5,127 |
$251K |
| 87631 |
|
2,700 |
2,545 |
$238K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,993 |
870 |
$227K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,254 |
2,972 |
$224K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
575 |
504 |
$182K |
| 80050 |
General health panel |
3,272 |
3,006 |
$178K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,588 |
1,326 |
$161K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,648 |
1,382 |
$160K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
666 |
463 |
$151K |
| A0425 |
Ground mileage, per statute mile |
805 |
659 |
$143K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
261 |
228 |
$143K |
| J3490 |
Unclassified drugs |
422 |
242 |
$142K |
| 81001 |
|
16,614 |
9,878 |
$136K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,541 |
2,772 |
$134K |
| 84703 |
|
2,928 |
2,498 |
$100K |
| 71046 |
Radiologic examination, chest; 2 views |
3,902 |
3,549 |
$96K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
946 |
838 |
$94K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
804 |
567 |
$92K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,333 |
1,271 |
$92K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,281 |
1,683 |
$90K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,712 |
655 |
$87K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,159 |
1,964 |
$85K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,131 |
1,008 |
$84K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
289 |
238 |
$83K |
| 87088 |
|
5,463 |
4,581 |
$81K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
825 |
802 |
$77K |
| 80053 |
Comprehensive metabolic panel |
15,187 |
12,649 |
$76K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,603 |
1,444 |
$72K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,110 |
1,021 |
$71K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,810 |
4,571 |
$65K |
| 73630 |
|
1,207 |
1,067 |
$56K |
| 59025 |
Fetal non-stress test |
2,811 |
1,247 |
$54K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,376 |
3,625 |
$54K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
458 |
270 |
$51K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,335 |
16,064 |
$45K |
| 73610 |
|
1,052 |
929 |
$44K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,309 |
3,324 |
$42K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,390 |
1,893 |
$40K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
327 |
281 |
$39K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,275 |
1,212 |
$39K |
| 73130 |
|
1,164 |
888 |
$36K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
450 |
376 |
$33K |
| 73562 |
|
752 |
644 |
$29K |
| 72100 |
|
746 |
709 |
$29K |
| 88142 |
|
1,353 |
1,294 |
$28K |
| 97161 |
|
286 |
284 |
$27K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
314 |
231 |
$26K |
| 73110 |
|
558 |
484 |
$24K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
442 |
421 |
$22K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,265 |
3,892 |
$20K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
68 |
64 |
$19K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,648 |
2,331 |
$18K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
340 |
324 |
$17K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,844 |
1,526 |
$17K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
250 |
233 |
$17K |
| 82948 |
|
1,738 |
1,201 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,645 |
3,121 |
$16K |
| 73030 |
|
489 |
438 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,263 |
1,004 |
$15K |
| J2060 |
Injection, lorazepam, 2 mg |
69 |
58 |
$14K |
| 85651 |
|
1,542 |
1,368 |
$14K |
| 99223 |
Prolong inpt eval add15 m |
104 |
102 |
$13K |
| 83690 |
|
4,560 |
3,891 |
$12K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
66 |
52 |
$12K |
| 83605 |
|
5,231 |
4,164 |
$11K |
| 99222 |
Initial hospital care, per day, moderate complexity |
122 |
118 |
$11K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
511 |
473 |
$11K |
| 83516 |
|
596 |
377 |
$10K |
| 87070 |
|
1,213 |
1,101 |
$10K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
165 |
155 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
1,334 |
1,173 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
300 |
286 |
$8K |
| 87590 |
|
738 |
687 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
102 |
100 |
$7K |
| 87490 |
|
737 |
686 |
$7K |
| 84484 |
|
2,090 |
1,535 |
$7K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
41 |
40 |
$7K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
115 |
115 |
$7K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
15 |
13 |
$6K |
| 87040 |
|
1,728 |
827 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,526 |
1,168 |
$6K |
| A4550 |
Surgical trays |
123 |
108 |
$5K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
3,453 |
2,039 |
$5K |
| 73140 |
|
90 |
81 |
$5K |
| 74018 |
|
109 |
101 |
$5K |
| G0378 |
Hospital observation service, per hour |
766 |
512 |
$5K |
| 86803 |
|
58 |
50 |
$5K |
| 87653 |
|
687 |
669 |
$5K |
| 83880 |
|
757 |
659 |
$4K |
| 62323 |
|
12 |
12 |
$4K |
| 83540 |
|
510 |
471 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
12 |
$4K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
685 |
625 |
$3K |
| 73564 |
|
71 |
56 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
627 |
356 |
$3K |
| 94762 |
|
19 |
14 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,694 |
1,388 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
71 |
42 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
25 |
25 |
$2K |
| 99233 |
Prolong inpt eval add15 m |
26 |
12 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,717 |
2,525 |
$2K |
| A6219 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
87 |
82 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
123 |
95 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
39 |
37 |
$2K |
| 73080 |
|
14 |
12 |
$2K |
| 86140 |
|
1,377 |
1,193 |
$1K |
| 88342 |
|
17 |
13 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
41 |
36 |
$1K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
16 |
13 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,231 |
2,087 |
$898.10 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
18 |
16 |
$877.30 |
| 85610 |
|
1,214 |
978 |
$795.96 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
13 |
13 |
$713.25 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
111 |
102 |
$646.79 |
| 86592 |
|
1,025 |
925 |
$594.69 |
| 99152 |
|
43 |
42 |
$575.99 |
| 84702 |
|
948 |
680 |
$523.09 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13 |
13 |
$429.17 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
614 |
567 |
$396.70 |
| 80061 |
Lipid panel |
2,312 |
2,172 |
$382.86 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,623 |
972 |
$354.57 |
| 86769 |
|
35 |
32 |
$300.92 |
| 84550 |
|
64 |
52 |
$293.77 |
| 86703 |
|
1,300 |
1,178 |
$254.54 |
| 84481 |
|
596 |
568 |
$251.76 |
| 93971 |
|
16 |
15 |
$251.16 |
| 73502 |
|
25 |
24 |
$206.95 |
| 84439 |
|
2,385 |
2,233 |
$195.23 |
| 73100 |
|
25 |
12 |
$166.20 |
| 84403 |
|
44 |
37 |
$151.52 |
| 82043 |
|
132 |
125 |
$129.98 |
| 83735 |
|
973 |
734 |
$122.97 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
12 |
$112.99 |
| 85378 |
|
690 |
631 |
$108.99 |
| 86901 |
|
1,200 |
1,075 |
$103.53 |
| 82550 |
|
499 |
393 |
$102.84 |
| 84460 |
|
224 |
192 |
$62.86 |
| 87045 |
|
84 |
78 |
$59.34 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13 |
13 |
$35.09 |
| 87177 |
|
14 |
13 |
$23.98 |
| 87340 |
|
624 |
579 |
$13.18 |
| 82607 |
|
535 |
490 |
$10.28 |
| 82950 |
|
526 |
510 |
$6.48 |
| 82565 |
|
142 |
118 |
$5.12 |
| 86900 |
|
897 |
796 |
$0.00 |
| 80074 |
|
261 |
229 |
$0.00 |
| 84450 |
|
214 |
185 |
$0.00 |
| 84520 |
|
117 |
103 |
$0.00 |
| 86431 |
|
41 |
39 |
$0.00 |
| A6530 |
Gradient compression stocking, below knee, 18-30 mmhg, each |
129 |
98 |
$0.00 |
| 83970 |
|
20 |
14 |
$0.00 |
| 88312 |
|
16 |
12 |
$0.00 |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
12 |
12 |
$0.00 |
| 83525 |
|
19 |
14 |
$0.00 |
| 86038 |
|
23 |
13 |
$0.00 |
| 82728 |
|
536 |
479 |
$0.00 |
| 82553 |
|
142 |
106 |
$0.00 |
| 81511 |
|
81 |
78 |
$0.00 |
| 86850 |
|
836 |
743 |
$0.00 |
| 86762 |
|
347 |
319 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
25 |
25 |
$0.00 |
| 85730 |
|
289 |
244 |
$0.00 |
| 82150 |
|
14 |
14 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
53 |
26 |
$0.00 |
| 83001 |
|
68 |
63 |
$0.00 |
| 82784 |
|
26 |
25 |
$0.00 |
| 86812 |
|
13 |
12 |
$0.00 |
| 83550 |
|
30 |
26 |
$0.00 |
| 83002 |
|
18 |
17 |
$0.00 |
| 84153 |
|
57 |
52 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
22 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
29 |
29 |
$0.00 |